Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Fradiomycin Sulfate
2. Neomycin
3. Neomycin Palmitate
4. Neomycin Sulfate
1. Framycetin (sulfate)
2. Fradiomycin B (sulfate); Neomycin B (sulfate)
3. Neomycin Sulfate
4. 4146-30-9
5. Bcp28374
6. Neomycin Sulfate; Neomycin Sulphate B
| Molecular Weight | 908.9 g/mol |
|---|---|
| Molecular Formula | C23H52N6O25S3 |
| Hydrogen Bond Donor Count | 19 |
| Hydrogen Bond Acceptor Count | 31 |
| Rotatable Bond Count | 9 |
| Exact Mass | 908.21442469 g/mol |
| Monoisotopic Mass | 908.21442469 g/mol |
| Topological Polar Surface Area | 602 Ų |
| Heavy Atom Count | 57 |
| Formal Charge | 0 |
| Complexity | 953 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 19 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 4 |
| 1 of 20 | |
|---|---|
| Drug Name | NEO-SYNALAR |
| Active Ingredient | FLUOCINOLONE ACETONIDE; NEOMYCIN SULFATE |
| Company | MEDIMETRIKS PHARMS (Application Number: A060700) |
| 2 of 20 | |
|---|---|
| Drug Name | NEOMYCIN AND POLYMYXIN B SULFATE |
| Active Ingredient | NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | WATSON LABS (Application Number: A062664); X GEN PHARMS (Application Number: A065106); X GEN PHARMS (Application Number: A065108) |
| 3 of 20 | |
|---|---|
| Drug Name | NEOSPORIN G.U. IRRIGANT |
| Active Ingredient | NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | MONARCH PHARMS (Application Number: A060707) |
| 4 of 20 | |
|---|---|
| Drug Name | NEOMYCIN AND POLYMYXIN B SULFATES AND BACITRACIN ZINC |
| Active Ingredient | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | AKORN (Application Number: A065088); BAUSCH AND LOMB (Application Number: A064064); PERRIGO CO TENNESSEE (Application Number: A060764) |
| 5 of 20 | |
|---|---|
| Drug Name | NEOSPORIN |
| Active Ingredient | BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | CASPER PHARMA LLC (Application Number: N050417) |
| 6 of 20 | |
|---|---|
| Drug Name | DEXASPORIN |
| Active Ingredient | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | BAUSCH AND LOMB (Application Number: A064135) |
| 7 of 20 | |
|---|---|
| Drug Name | MAXITROL |
| Active Ingredient | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | NOVARTIS PHARMS CORP (Application Number: N050023); NOVARTIS PHARMS CORP (Application Number: N050065); SANDOZ INC (Application Number: A062341) |
| 8 of 20 | |
|---|---|
| Drug Name | NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE |
| Active Ingredient | DEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | BAUSCH AND LOMB (Application Number: A064063); PERRIGO CO TENNESSEE (Application Number: A062938) |
| 9 of 20 | |
|---|---|
| Drug Name | NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN |
| Active Ingredient | GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | AMRING PHARMS (Application Number: A065187); BAUSCH AND LOMB (Application Number: A064047) |
| 10 of 20 | |
|---|---|
| Drug Name | NEOSPORIN |
| Active Ingredient | GRAMICIDIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | MONARCH PHARMS (Application Number: A060582) |
| 11 of 20 | |
|---|---|
| Drug Name | CORTISPORIN |
| Active Ingredient | HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | MONARCH PHARMS (Application Number: N050218) |
| 12 of 20 | |
|---|---|
| Drug Name | CASPORYN HC |
| Active Ingredient | HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | CASPER PHARMA LLC (Application Number: N060613) |
| 13 of 20 | |
|---|---|
| Drug Name | CORTISPORIN |
| Active Ingredient | HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | MONARCH PHARMS (Application Number: N050479) |
| 14 of 20 | |
|---|---|
| Drug Name | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE |
| Active Ingredient | HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | AMRING PHARMS (Application Number: A065216); AMRING PHARMS (Application Number: A065219); BAUSCH AND LOMB (Application Number: A064053); SANDOZ INC (Application Number: A062423); SANDOZ INC (Application Number: A062488); SANDOZ INC (Application Number: A062874) |
| 15 of 20 | |
|---|---|
| Drug Name | OTICAIR |
| Active Ingredient | HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | BAUSCH AND LOMB (Application Number: A064065) |
| 16 of 20 | |
|---|---|
| Drug Name | BACITRACIN-NEOMYCIN-POLYMYXIN W/ HYDROCORTISONE ACETATE |
| Active Ingredient | BACITRACIN ZINC; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | PERRIGO CO TENNESSEE (Application Number: A062166) |
| 17 of 20 | |
|---|---|
| Drug Name | CORTISPORIN |
| Active Ingredient | BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | MONARCH PHARMS (Application Number: N050168) |
| 18 of 20 | |
|---|---|
| Drug Name | NEOMYCIN AND POLYMYXIN B SULFATES, BACITRACIN ZINC AND HYDROCORTISONE |
| Active Ingredient | BACITRACIN ZINC; HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE |
| Company | AKORN (Application Number: A065213); BAUSCH AND LOMB (Application Number: A064068) |
| 19 of 20 | |
|---|---|
| Drug Name | COLY-MYCIN S |
| Active Ingredient | COLISTIN SULFATE; HYDROCORTISONE ACETATE; NEOMYCIN SULFATE; THONZONIUM BROMIDE |
| Company | ENDO PHARMS INC (Application Number: N050356) |
| 20 of 20 | |
|---|---|
| Drug Name | NEOMYCIN SULFATE |
| Active Ingredient | NEOMYCIN SULFATE |
| Company | BRECKENRIDGE PHARM (Application Number: A065468); LANNETT CO INC (Application Number: A204435); TEVA (Application Number: A060304); X GEN PHARMS (Application Number: A065220) |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Protein Synthesis Inhibitors
Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Bykomcyin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bykomcyin, including repackagers and relabelers. The FDA regulates Bykomcyin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bykomcyin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bykomcyin supplier is an individual or a company that provides Bykomcyin active pharmaceutical ingredient (API) or Bykomcyin finished formulations upon request. The Bykomcyin suppliers may include Bykomcyin API manufacturers, exporters, distributors and traders.
Bykomcyin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bykomcyin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bykomcyin GMP manufacturer or Bykomcyin GMP API supplier for your needs.
A Bykomcyin CoA (Certificate of Analysis) is a formal document that attests to Bykomcyin's compliance with Bykomcyin specifications and serves as a tool for batch-level quality control.
Bykomcyin CoA mostly includes findings from lab analyses of a specific batch. For each Bykomcyin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bykomcyin may be tested according to a variety of international standards, such as European Pharmacopoeia (Bykomcyin EP), Bykomcyin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bykomcyin USP).
LOOKING FOR A SUPPLIER?
